Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.

“Understanding the sex differences in obesity-related HFpEF is of great importance,” one cardiologist explained. “Obesity and visceral adiposity are key drivers of HFpEF development and progression, and this may be even more amplified in women."

The new-look diet was linked to significant weight loss and reductions in HbA1C levels. Researchers see it as a potential alternative to immediately putting patients on new medications. 

“While the use of cannabis continues to gain popularity, its broader effects on public health within the general population are not yet fully understood,” one researcher said.

A JACC report card highlights excess cardiovascular mortality among Black Americans and "persistent and tragic inequities" in cardiovascular care.

The WISEWOMAN program proved to be a useful intervention to screen low-income, uninsured women and offer them risk reduction counseling to improve blood pressure, diet and physical activity.

Researchers explored data from 23 different studies, identifying a “positive and almost linear association” between alcohol consumption and hypertension. 

According to the FDA, a total of 10 people have been hospitalized due to symptoms associated with these products. They are marketed as a "leading form of microdosing."